Skip Navigation
Skip to contents

ICoLA 2019

Today : 2019.12.09
D- -95
The 8th International Congress on Lipid & Atherosclerosis (ICoLA)
The 58th Fall Conference of the Korean Society of Lipid & Atherosclerosis
September 5 (Thu) ~ 7 (Sat), 2019
Conrad Seoul Hotel, Korea

Keynote Lectures

  • HOME
  • Program
  • Keynote Lectures
Keynote Lecture 1
Dr. Walsh was Arm V. Chobanian Distinguished Professor of Cardiovascular Medicine, Boston University School of Medicine. Recently, he moved to University of Virginia School of Medicine. He has published many outstanding papers in the journals such as Science, Nature, and Nature Medicine. His laboratory has examined molecular events that drive cardiovascular cell growth, differentiation and apoptosis. Over the past decade his laboratory has been investigating mechanisms of inter-tissue communication and how these systems contribute to physiological versus pathological tissue growth in the cardiovascular system. His recent research topic is clonal hematopoiesis in cardiovascular area. Based on the recent findings, he will announce new findings on clonal hematopoiesis as a new causal risk factor for cardiovascular disease.
ChairpersonChee Jeong Kim (Chung-Ang University, Korea)
Sep. 6 (Fri.)
Room 1+2+3
09:00-09:30 Killer Clones: Clonal Hematopoiesis as a New Causal Risk Factor for Cardiovascular Disease Kenneth Walsh, Ph.D. (University of Virginia, USA)
Keynote Lecture 2
Dr. Gregory G. Schwartz is a Professor of Medicine (Division of Cardiology) at the University of Colorado and Chief of the Cardiology Section at the Rocky Mountain Regional VA Medical Center in Aurora, Colorado (USA). Dr. Schwartz’s research interests focus on preventive cardiology, lipids, and acute coronary care. His clinical research has focused on trials of lipid and metabolic interventions in coronary heart disease, including placebo-controlled cardiovascular outcome trials that establish the efficacy of intensive statin treatment (MIRACL, 2001) and PCSK9 inhibition (ODYSSEY OUTCOMES, 2018) after acute coronary syndrome. Dr. Schwartz also directs a large animal physiology laboratory that investigates translational questions in myocardial energy metabolism and ischemic protection. In ICoLA 2019, he will deliver a lecture entitled “Metformin: Is it a Cardiovascular Drug?” based on his scientific research experience.
ChairpersonKyong Soo Park (Seoul National University, Korea)
Sep. 7 (Sat.)
Room 1+2+3
09:00-09:30 Metformin: Is it a Cardiovascular Drug? Gregory G. Schwartz, M.D., Ph.D. (University of Colorado, USA)
Organized by KSoLA

The Korean Society of Lipid and Atherosclerosis

No.707, Mapoacro Tower, 68 Mapo-daero, Mapo-gu, Seoul 04168, Korea
  • Business Registration Number : 110-82-60956
  • Chairman : Joong-Yeol Park

Secretariat of ICoLA 2019 │ People & Value, Inc.

#1001 Botanic Park Tower, Magok-joongang-ro 161-17, Gangseo-gu, Seoul, Korea

Copyrights 2019 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.